Patents
Patents for C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group (62,773)
05/2011
05/25/2011CN101328169B Diethylcarbamyl-substituted thiazole dihydropyrimidine
05/25/2011CN101272783B (indol-3-yl)-heterocycle derivatives as agonists of the cannabinoid CB1 receptor
05/25/2011CN101213184B Heteroaryl-substituted amides comprising an unsaturated or cyclic linker group, and their use as pharmaceuticals
05/24/2011US7947830 Substituted propenyl piperazine derivatives as novel inhibitors of histone deacetylase
05/24/2011US7947713 Tripeptidyl peptidase inhibitors
05/24/2011US7947711 Bicyclic-substituted amines as histamine-3 receptor ligands
05/24/2011US7947700 Carboxylic acid amides, the preparation thereof and their use as medicaments
05/24/2011US7947683 3-(1,2,4-triazol-3-ylalkyl) azabicyclo (3.1.0) hexane derivatives as modulators of dopamine D3 receptors
05/24/2011CA2499690C Diaryl ethers as opioid receptor antagonist
05/24/2011CA2493026C Vegfr-2 and vegfr-3 inhibitory anthranilamide pyridines
05/24/2011CA2490888C Diaminopyrimidinecarboxamide derivative
05/24/2011CA2477601C 5-phenylthiazole derivatives and use as pi3 kinase inhibitors
05/24/2011CA2467552C Nicotin-or isonicotin benzothiazole derivatives
05/19/2011WO2011060000A1 Hepatitis c virus inhibitors
05/19/2011WO2011059042A1 Aromatic ring compound
05/19/2011WO2011058963A1 1-heterodiene derivative and noxious organism control agent
05/19/2011WO2011058766A1 Aryl carboxamide derivatives as ttx-s blockers
05/19/2011WO2011058763A1 Aminothiazine or aminooxazine derivative having amino linker
05/19/2011WO2011058139A1 A compound, a process for its preparation, a pharmaceutical composition, use of a compound, a method for modulating or regulating serine/threonine kinases and a serine/threonine kinases modulating agent
05/19/2011WO2011057973A1 Oxazoline derivatives for treatment of cns disorders
05/19/2011WO2011057892A1 2,3-dihydrobenzoxazine and 2,3-dihydrobenzothiazine derivates as hif-inhibitors for the treatment of cancer and inflammatory diseases
05/19/2011WO2011057805A1 Tubulin inhibitors
05/19/2011WO2011017342A3 Mesoionic pesticides
05/19/2011WO2011015524A3 Fungicide heterocycles derivatives
05/19/2011WO2010111634A3 Renin inhibitors
05/19/2011US20110118470 Nitrogen-containing aromatic derivatives
05/19/2011US20110118460 Process for the synthesis of quetiapine
05/19/2011US20110118314 Piperidine analogs as glycogen synthase activators
05/19/2011US20110118311 Azole compound
05/19/2011US20110118282 Soluble Guanylate Cyclase Activators
05/19/2011US20110118281 Compounds for inflammation and immune-related uses
05/19/2011US20110118260 Glucocorticoid receptor agonist comprising 2,2,4-trimethyl-6-phenyl-1,2-dihydroquinoline derivatives having substituted oxy group
05/19/2011US20110118248 Heteroaryl sulfonamides and CCR2/CCR9
05/19/2011US20110118246 Novel Compounds
05/19/2011US20110118245 Raf kinase modulator compounds and methods of use thereof
05/19/2011US20110118241 6-Pyridin-3-YL-3,4-Dihydro-1H-Quinolin-2-One Derivatives and Related Compounds as Inhibitors of the Human Aldosterone Synthase CYP11B2
05/19/2011US20110118236 Heterocyclic compound
05/19/2011US20110118232 Pyrimidine compounds and use thereof
05/19/2011US20110117591 Chemical probe compounds that become fluorescent upon reduction, and methods for their use
05/19/2011US20110117055 Methods of Treating Hepatitis C Virus with Oxoacetamide Compounds
05/19/2011CA2780772A1 Selective sphingosine 1 phosphate receptor modulators and methods of chiral synthesis
05/19/2011CA2780682A1 1-heterodiene derivative and pest control agent
05/19/2011CA2780641A1 Selective heterocyclic sphingosine 1 phosphate receptor modulators
05/19/2011CA2780568A1 Oxazoline derivatives for treatment of cns disorders
05/19/2011CA2780031A1 A compound, a process for its preparation, a pharmaceutical composition, use of a compound, a method for modulating or regulating serine/threonine kinases and a serine/threonine kinases modulating agent
05/18/2011EP2322520A1 Aralkyl substituted piperidine or piperazine derivatives and their use for treating schizophrenia
05/18/2011EP2322516A1 Intermediates for the preparation of Macrocyclic inhibitors of hepatitis c virus
05/18/2011EP2321862A1 Organic semiconductor material and light-emitting element, light-emitting device, lighting system, and electronic device using the same
05/18/2011EP2321309A1 Benzothiazoles and aza-analogues thereof use as antibacterial agents
05/18/2011EP2321303A2 Compounds that modulate intracellular calcium
05/18/2011EP2321296A1 Substituted 5-aminopyrazoles and use thereof
05/18/2011EP2321289A1 Selective glycosidase inhibitors and uses thereof
05/18/2011EP2321288A1 Oxazole derivatives useful as inhibitors of faah
05/18/2011EP2321283A1 2, 6-diamino-pyrimidin- 5-yl-carboxamides as syk or jak kinases inhibitors
05/18/2011EP2321274A1 Pyrrolidinyl and piperidinyl compounds useful as nhe-1 inhibitors
05/18/2011EP2320738A1 Substituted aminothiazole derivatives, pharmaceutical compositions, and methods of use
05/18/2011EP2320737A1 Pyrazoloý1,5-a¨pyridines as mark inhibitors
05/18/2011EP2099759B1 Antibacterial quinoline derivatives
05/18/2011EP1667984B1 Gamma-secretase inhibitors
05/18/2011EP1529053B1 Macrolide compounds endowed with antiinflammatory activity
05/18/2011EP1467969B1 Dna minor groove binding compounds
05/18/2011EP1373210B1 Heterocyclic diamide invertebrate pest control agents
05/18/2011EP1318140B1 Novel amide derivatives and medicinal use thereof
05/18/2011CN102066368A 1,2-benzisothiazole compounds useful for combating animal pests
05/18/2011CN102066367A Thiazolyl piperdine derivatives
05/18/2011CN102066366A Novel substituted pyridin-2-ones and pyridazin-3-ones
05/18/2011CN102066365A Thiophene or thiazole derivatives and their use as PI3K inhibitors
05/18/2011CN102066340A 2, 6-diamino-pyrimidin- 5-yl-carboxamides as SRK or JAK kinases inhibitors
05/18/2011CN102066339A 2, 6-diamino- pyrimidin- 5-yl-carboxamides as SYK or JAK kinases inhibitors
05/18/2011CN102066335A Substituted pyrimidin-5-carboxamides 281
05/18/2011CN102066326A Pyridone compound
05/18/2011CN102066322A Compound having NPY Y5 receptor antagonist activity
05/18/2011CN102060852A Quinoline complexes, preparation method thereof, quinoline complex-containing catalyst and use of catalyst in catalysis of vinyl polymerization
05/18/2011CN102060772A N-(4-substituted phenyl)-1H-3-pyrazolecarboxamide cyclin dependent kinase 2 inhibitors and application thereof
05/18/2011CN101189231B Novel cyclic aminophenylalkanoic acid derivative
05/17/2011US7943803 Clathrate compound, method for controlling concentration of aqueous agricultural chemical active ingredient solution, and agricultural chemical formulation
05/17/2011US7943777 Fluorescent chemical compounds having high selectivity for double stranded DNA, and methods for their use
05/17/2011US7943774 Heterocyclyl-substituted thiazoles as crop protection agents
05/17/2011US7943768 Piperazine compounds useful as antagonists of C-C chemokines (Ccr2b and CcrS) for the treatment of inflammatory diseases
05/17/2011US7943645 Piperidine compounds for use as orexin receptor antagonist
05/17/2011US7943627 2,4-diaminopyrimidine derivatives
05/17/2011US7943619 Isoxazolo-pyridazine derivatives
05/17/2011US7943607 Heteroaryl benzamide derivatives for use as GLK activators in the treatment of diabetes
05/17/2011US7943605 Compounds comprising a lactam or a lactam derivative moiety, processes for making them, and their uses
05/17/2011CA2487840C Substituted 1-piperazinylacylpiperidine derivatives, their preparation and their therapeutic application
05/17/2011CA2473790C 1,4-dihydropyridine and pyridine compounds as calcium channel blockers
05/17/2011CA2470365C 4-oxoquinoline compound and use thereof as hiv integrase inhibitor
05/12/2011WO2011057054A1 Aryl- and heteroarylcarbonyl derivatives of hexahydroindenopyridine and octahydrobenzoquinoline
05/12/2011WO2011056652A1 Imidazole derivatives as ido inhibitors
05/12/2011WO2010093650A3 Compositions and methods for controlling nematodes
05/12/2011WO2008079988A9 Quinazolines for pdk1 inhibition
05/12/2011US20110112295 Tricyclic spacer systems for nonlinear optical devices
05/12/2011US20110112290 process for the preparation of quetiapine
05/12/2011US20110112154 Compounds, compositions and methods
05/12/2011US20110112149 Epothilone analogues, their pharmaceutical compositions, their use and their prepa rations
05/12/2011US20110112143 Allosteric modulators of metabotropic glutamate receptors
05/12/2011US20110112142 Novel estrogen receptor ligands
05/12/2011US20110112118 2,4-Diaminoquinazolines for Spinal Muscular Atrophy
05/12/2011US20110112110 Antiproliferative compounds and therapeutic uses thereof
05/12/2011US20110112103 5-hydroxypyrimidine-4-carboxamide compound